Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

被引:20
|
作者
Mezheyeuski, Artur [1 ,2 ]
Hrynchyk, Ina [3 ]
Karlberg, Mia [1 ]
Portyanko, Anna [2 ]
Egevad, Lars [1 ]
Ragnhammar, Peter [1 ]
Edler, David [4 ]
Glimelius, Bengt [5 ]
Ostman, Arne [1 ]
机构
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Belarusian State Med Univ, Dept Pathol, Minsk, BELARUS
[3] City Clin Pathologoanat Bur, Minsk, BELARUS
[4] Karolinska Univ Hosp Solna, Dept Mol Med & Surg, Stockholm, Sweden
[5] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
基金
瑞典研究理事会;
关键词
THYMIDYLATE SYNTHASE EXPRESSION; COLORECTAL-CANCER; ADJUVANT THERAPY; MISMATCH REPAIR; FLUOROURACIL; CHEMOTHERAPY; INTERFACE; PATTERN; BENEFIT; MARKER;
D O I
10.1038/srep36149
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The complexity of tumor histomorphology reflects underlying tumor biology impacting on natural course and response to treatment. This study presents a method of computer-aided analysis of tissue sections, relying on multifractal (MF) analyses, of cytokeratin-stained tumor sections which quantitatively evaluates of the morphological complexity of the tumor-stroma interface. This approach was applied to colon cancer collection, from an adjuvant treatment randomized study. Metrics obtained with the method acted as independent markers for natural course of the disease, and for benefit of adjuvant treatment. Comparative analyses demonstrated that MF metrics out-performed standard histomorphological features such as tumor grade, budding and configuration of invasive front. Notably, the MF analyses-derived "alpha(max)" -metric constitutes the first response-predictive biomarker in stage II-III colon cancer showing significant interactions with treatment in analyses using a randomized trial-derived study population. Based on these results the method appears as an attractive and easy-to-implement tool for biomarker identification.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] A CIRCRNA SIGNATURE PREDICTS POSTOPERATIVE RECURRENCE IN STAGE II/III COLON CANCER
    Ju, Huai-Qiang
    Zhao, Qi
    Wang, Feng
    Lan, Ping
    Wang, Zixian
    Xu, Rui-Hua
    GUT, 2019, 68 : A30 - A30
  • [22] Glycemic Variability in Patients With Stage II-III Colon Cancer Treated With Surgery and Adjuvant Chemotherapy
    Mandolfo, Natalie Rasmussen
    Berger, Ann M.
    Struwe, Leeza A.
    Shade, Marcia Y.
    Goldner, Whitney
    Klute, Kelsey
    Langenfeld, Sean J.
    Hammer, Marilyn J.
    ONCOLOGY NURSING FORUM, 2022, 49 (06) : 571 - 584
  • [23] Standards in adjuvant treatment of stage II and III in colon cancer
    Labianca, Roberto
    Garassino, Marina Chiara
    ANNALS OF ONCOLOGY, 2006, 17 : 37 - 37
  • [24] Glycemic Variability Within 1 Year Following Surgery for Stage II-III Colon Cancer
    Mandolfo, Natalie Rasmussen
    Berger, Ann M.
    Struwe, Leeza
    Hanna, Kathleen M.
    Goldner, Whitney
    Klute, Kelsey
    Langenfeld, Sean
    Hammer, Marilyn
    BIOLOGICAL RESEARCH FOR NURSING, 2022, 24 (01) : 64 - 74
  • [25] Prognosis of Different Histological Types in Patients with Stage II and III Colon Cancer
    Yasmeen Z. Qwaider
    Naomi M. Sell
    Caitlin E. Stafford
    Chloe Boudreau
    Hiroko Kunitake
    Robert N. Goldstone
    Rocco Ricciardi
    Liliana G. Bordeianou
    Christy E. Cauley
    David L. Berger
    Journal of Gastrointestinal Surgery, 2022, 26 : 476 - 478
  • [26] Prognosis of Different Histological Types in Patients with Stage II and III Colon Cancer
    Qwaider, Yasmeen Z.
    Sell, Naomi M.
    Stafford, Caitlin E.
    Boudreau, Chloe
    Kunitake, Hiroko
    Goldstone, Robert N.
    Ricciardi, Rocco
    Bordeianou, Liliana G.
    Cauley, Christy E.
    Berger, David L.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 26 (02) : 476 - 478
  • [27] Artificial intelligence (AI) -powered spatial analysis of tumor-infiltrating lymphocytes (TIL) for prediction of prognosis in stage II-III resectable colon cancer.
    Lim, Yoojoo
    Choi, Songji
    Oh, Hyeon Jeong
    Song, Sanghoon
    Kim, Sukjun
    Song, Heon
    Park, Seonwook
    Kim, Ji-Won
    Kim, Jin Won
    Kim, Jee Hyun
    Kang, Minsu
    Kang, Sung-Bum
    Kim, Duck-Woo
    Oh, Heung-Kwon
    Lee, Hye Seung
    Lee, Keun-Wook
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 211 - 211
  • [28] Stage II and Stage III Colon Cancer Treatment Advances and Future Directions
    Rousseau, Benoit
    Chibaudel, Benoist
    Bachet, Jean-Baptiste
    Larsen, Annette K.
    Tournigand, Christophe
    Louvet, Christophe
    Andre, Thierry
    De Gramont, Aimery
    CANCER JOURNAL, 2010, 16 (03): : 202 - 209
  • [29] Reply: Comment on ‘A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients’
    J Szkandera
    M Pichler
    M Stotz
    A Gerger
    British Journal of Cancer, 2013, 109 : 3126 - 3127
  • [30] Reply: Comment on 'A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'
    Szkandera, J.
    Pichler, M.
    Stotz, M.
    Gerger, A.
    BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 3126 - 3127